Bruker Cellular Analysis

🚀 New Application Note for Cell Line Development Researchers! 🔬 Are you working with bispecific antibodies and looking to streamline your cell line development process? Our latest Application Note demonstrates how to identify high-quality bispecific antibodies in just days using the Beacon® platform with SpotLight reagents! In this Application Note, you'll discover how to: ✅ Identify top clones early, with optimal growth, titer, and product quality attributes—before scale up. 🔍 Screen a broad range of cell lines, including those expressing traditional mAbs and complex formats like bispecific antibodies with Lambda-Kappa light chains. ⚡ Accelerate the identification of cell lines producing molecules in the desired format, cutting down development timelines. Download now: https://hubs.ly/Q02VG6JR0 #CellLineDevelopment #AntibodyResearch #BeaconPlatform #BiologicsDevelopment #BiotechInnovation #BispecificAntibodies

🧬 NIH’s Breakthrough in Coronavirus Research Discover how Dr. Joshua Tan from the NIH leveraged the Beacon® platform to identify broadly neutralizing antibodies targeting the coronavirus fusion peptide across multiple variants. This study, published in Science, highlights how our platform is advancing vaccine development against evolving viral threats. 📖 Explore the full case study https://hubs.ly/Q02VYNzm0 #AntibodyDiscovery #VaccineDevelopment #BeaconPlatform #BiotechResearch #Pharma

The Beacon Select System for Antibody Discovery now comes equipped with Advanced Reagents and Chips designed to streamline Monoclonal Antibody Discovery like never before. Customize all assays with multiple fluorophores, detection molecules, and your available antigens to efficiently screen Single B cells. Tailor your discovery process to achieve faster, more accurate results! https://hubs.ly/Q02RP6R70

I’m incredibly proud of Jessica Schmeling for doing an amazing job presenting her research poster at the 2024 AACR Tumor Immunology and Immunotherapy conference in Boston! As a Research Technician in our lab, Jess decided she wanted to challenge herself and take on an independent research project focused on identifying tumor- and T cell-centric parameters that shape immunogenicity and how these ultimately result in productive anti-tumor CD8+ T cell responses. Within a few months she's already made some incredible discoveries, which have allowed her to share her findings at national conferences and she's also been invited to give a talk internationally at the 52nd Annual Scientific Meeting of the Australian and New Zealand Society for Immunology at the end of November! She has a very bright future in research! I'd like to give a special thank you to Wayne Hickok, M.Sc. for helping us get our hands on some antigen presenting bead (APB) kits on such short notice and the entire team at Bruker Cellular Analysis for supporting our research! People stopping by Jess' poster were incredibly impressed by how well the APBs worked to expand neoantigen-specific CD8+ T cells! #research #immunotherapy #immunology #immunooncology

🌟 Exciting day at the Beacon Optofluidic User Group Meeting here at Monash University, Australia! 🎉 We’re connecting with brilliant experts, researchers, and innovators, discussing the latest advancements in Antibody Discovery and Immune Profiling. From thought-provoking presentations to hands-on demos, there's a lot of energy and inspiration in the room!✨

🦠 Redefining Plasmablasts at Emory Vaccine Center Read how Dr. Frances Eun-Hyung Lee from the Emory Vaccine Center used Bruker’s optofluidic platform to challenge the traditional understanding of human plasmablasts. This fascinating study, published in Scientific Reports, explores new insights into antibody-secreting cells. 📖 Dive into the case study https://hubs.ly/Q02RPbBG0 #AntibodyResearch #Plasmablasts #BeaconPlatform #Immunology #Pharma

Webinar with The Antibody Society: Accelerating Therapeutic Antibody Discovery: Innovative Technologies Transforming Hit Generation and Lead Characterization. Monoclonal antibody discovery is revolutionizing treatments for cancer, autoimmune diseases, and more. With new demands on safety, efficacy, and functional characterization, breakthrough technologies like Beacon® optofluidic are key to fast-tracking the discovery of successful antibodies. 🔬 What you’ll learn: • Cutting-edge screening for plasma and memory B cells • How Bruker Cellular Analysis is accelerating Antibody discovery and characterization timelines 📅 Date: October 31, 2024 I 11:00 AM ET 🎤 Speakers: • Dr. Yu Liang, PhD – VP of Ab Drug Discovery, GenScript ProBio • Vincent Pai – Director, Product Management, Bruker Cellular Analysis 🚨 Register today: https://hubs.ly/Q02S597G0 #AntibodyDiscovery #Biotechnology #theantibodysociety

Join us in Chicago, IL next week to experience groundbreaking innovation and see firsthand how you can transform your research with the unparalleled ability to perform real-time, multi-modal analysis on live single cells. Seminar details ⤵️   Northwestern University 📅 Date: October 21, 2024 🕰 Time: 12:00 - 2:00 PM 📍 Location: Simpson Querrey Auditorium, SQBRC 1-230, 303 East Superior St., Chicago, IL 60611   University of Chicago 📅 Date: October 23, 2024 🕰 Time: 10:00 - 11:00 AM 📍 Location: University of Chicago - KCBD Auditorium 1103   Learn about utilizing Beacon® for:   · Single-cell Multi-omics: Deeply characterize, profile, and map your cell populations of interest. · Antibody Discovery: Characterize single B-cells and reduce the time and cost to identify difficult antibody lead candidates. · Cell Line Development: Identify top producers with favorable product quality attributes within five days of cloning.   We look forward to seeing you there!

🚀 Exciting News! Join us at the Festival of Biologics at booth 1127! Discover Bruker Cellular Analysis’ Beacon—a function-first platform that enables exquisite selective live single-cell control. It’s designed to advance your research and enhance your discoveries. We can't wait to connect with you! Gareth Jones Mio Muelthaler #antibodydiscovery #singlecell #function #affinity

🐫 Discovering Heavy-Chain-Only Antibodies in Alpacas Learn how Dr. Mariya Shapiro from the Twist Bioscience utilized Bruker’s Beacon® platform to successfully isolate heavy-chain-only antibodies from alpacas. Published in Antibody Therapeutics, this case study shows how the Beacon® platform enables unique discoveries in diverse species. 📖 Read the full case study https://hubs.ly/Q02RPbBF0 #AntibodyDiscovery #HCAbs #BeaconPlatform #BiotechInnovation #Pharma